The Symbiotec Pharmalab IPO began on 24-August-2026. It will close on 27-August-2026. The Total IPO Size is 1,757 Crores. The company set its IPO price at Rs 988 per share.
There are three basic categories in Symbiotec Pharmalab Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.
Symbiotec Pharmalab are are a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms- organic chemistry, biotechnology and complex injectables..
They have a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients (“APIs”) in volume terms in Fiscal 2026, with a global volume market share of 38.2% in corticosteroid and 23.8% in steroidal-hormone APIs (excluding androstenedione and hydroxyprogesterone caproate)
They are the only Indian and global company to have a presence across the top 10 corticosteroid and steroidal-hormone APIs in Fiscal 2026.
Symbiotec Pharmalab IPO Promoters
Anil Satwani, Kashish Satwani, Sushil Satwani and Satwani Holdings LLP are the promoters of the company.
Symbiotec Pharmalab Date, Details & Price Band
The Symbiotec Pharmalab Price Band, IPO Dates, Market lot and other details are mentioned in the table below.
| IPO Opening Dates | 24-August-2026 |
| IPO Closing Dates | 27-August-2026 |
| Price | 938-988 Rs |
| Fresh Issue | 150 Crores |
| Offer for sale | 1,607 Crores |
| Total IPO size | 1,757 Crores |
| Face Value | 2 INR Per Share |
| Issue Type | Book Built Issue |
| Listing On | NSE, BSE |
| Pre IPO Market Cap | 6,244.43 Cr (on Upper Price) |
Symbiotec Pharmalab Market Lot
The Symbiotec Pharmalab minimum market lot is 15 shares, with a ₹14,820 application amount.
| Lot | No of Shares | Amount | |
| Retail Minimum | 1 | 15 | ₹14,820 |
| Retail Maximum | 13 | 195 | ₹1,92,660 |
| S-HNI Minimum | 14 | 210 | ₹2,07,480 |
| S-HNI Maximum | 67 | 1,005 | ₹9,92,940 |
| B-HNI Minimum | 68 | 1,020 | ₹10,07,760 |
Restated Consolidated Financial Information (Amt. in Crore)
| Total Assets | Total Revenue | Profit After Tax | |
| 31-Mar-26 | 1,780.79 | 872.26 | 109.90 |
| 31-Mar-25 | 1,579.65 | 755.98 | 96.79 |
| 31-Mar-24 | 1,294.79 | 723.33 | 100.06 |
Symbiotec Pharmalab GMP & Grey Market Premium
The Symbiotec Pharmalab GMP (Grey Market Premium) has started today. Check the Latest Symbiotec Pharmalab GMP, Kostak Rates, and Subject to Sauda Price here.
Symbiotec Pharmalab Prospectus
The Symbiotec Pharmalab Prospectus is Available on the NSE/BSE and SEBI websites, as well as on our Portal. Please click here to download the Symbiotec Pharmalab Prospectus.
| DRHP | Download |
| RHP | Download |
| Anchor Investors List | Download |
Symbiotec Pharmalab Allotment Date & Details
| Allotment Date | 28-August-2026 |
| Initiation of refunds | 31-August-2026 |
| Transfer of shares to Demat accounts | 31-August-2026 |
| Listing Date | 01-September-2026 |
| Check Allotment Status | Click here |
Symbiotec Pharmalab Registrar
MUFG Intime India Private Limited (Formerly Link Intime India Private Limited)
C-101, Embassy 247, L.B.S. Marg, Vikhroli
(West), Mumbai 400 083, Maharashtra, India
Telephone: +91 810 811 4949
Email: symbiotecpharmalab.ipo@in.mpms.mufg.com
Investor grievance email: symbiotecpharmalab.ipo@in.mpms.mufg.com
Website: www.in.mpms.mufg.com
Contact person: Shanti Gopalkrishnan
SEBI Registration No: INR000004058
Symbiotec Pharmalab Contact Address
385/2, Pigdamber, Rau, Mhow, Indore,
Madhya Pradesh, 453331
+91 731 667 6405
secretarial@symbiotec.com
Symbiotec Pharmalab Lead Managers
JM Financial Limited
7th Floor, Cnergy Appasaheb Marathe Marg
Prabhadevi, Mumbai 400 025, Maharashtra,
India
Telephone: +91 22 6630 3030
E-mail: symbiotec.ipo@jmfl.com
Investor Grievance email:
grievance.ibd@jmfl.com
Website: www.jmfl.com
Contact Person: Prachee Dhuri
SEBI Registration No.: INM000010361
Avendus Capital Private Limited
Platina Building, 9th Floor, 901, Plot No C-59,
Bandra Kurla Complex, Bandra (East),
Mumbai – 400 051, Maharashtra, India
Telephone: +91 22 6648 0050
Email: symbiotec.ipo@avendus.com
Investor grievance email:
investorgrievance@avendus.com
Website: www.avendus.com
Contact person: Sarthak Sawa / Ananya Chawla
SEBI Registration No: INM000011021
Motilal Oswal Investment Advisors Limited
Motilal Oswal Tower, Rahimtullah Sayani
Road, Opposite Parel ST Depot, Prabhadevi,
Mumbai – 400 025, Maharashtra, India
Telephone: +91 22 7193 4380
E-mail: spl.ipo@motilaloswal.com
Investor Grievance E-mail:
moiaplredressal@motilaloswal.com
Website: www.motilaloswal.com
Contact Person: Kunal Thakkar/Vaibhav Shah
SEBI Registration No.: INM000011005
Nomura Financial Advisory and Securities (India) Private Limited
Ceejay House, Level 11, Plot F, Shiv Sagar
Estate, Dr. Annie Besant Marg, Worli, Mumbai
– 400 018, Maharashtra, India
Telephone: +91 22 4037 4037
E-mail: symbiotecipo@nomura.com
Investor Grievance E-mail:
investorgrievances-in@nomura.com
Website: www.nomuraholdings.com/company/group/asi
a/india/index.html
Contact Person: Vishal Kanjani / Chirag Shah
SEBI Registration No.: INM000011419
